Group One Trading
AZN icon

Group One Trading’s AstraZeneca AZN Stock Holding History

Group One Trading’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8M Buy
59,900
+15,750
+36% +$3.04M 0.02% 739
2025
Q4 		$8.12M Buy
44,150
+20,350
+86% +$3.57M 0.01% 1090
2025
Q3 		$3.65M Sell
23,800
-57,450
-71% -$8.7M 0.01% 1767
2025
Q2 		$11.4M Sell
81,250
-4,250
-5% -$596K 0.03% 730
2025
Q1 		$12.6M Buy
85,500
+66,350
+346% +$9.6M 0.04% 527
2024
Q4 		$2.51M Sell
19,150
-18,200
-49% -$2.55M 0.01% 1713
2024
Q3 		$5.82M Buy
37,350
+35,550
+1,975% +$5.74M 0.02% 918
2024
Q2 		$281K Sell
1,800
-1,850
-51% -$278K ﹤0.01% 3102
2024
Q1 		$495K Sell
3,650
-42,500
-92% -$5.63M ﹤0.01% 2733
2023
Q4 		$6.22M Sell
46,150
-23,450
-34% -$3.05M 0.02% 970
2023
Q3 		$9.43M Buy
69,600
+4,950
+8% +$676K 0.03% 554
2023
Q2 		$9.25M Buy
64,650
+2,200
+4% +$324K 0.03% 548
2023
Q1 		$8.67M Sell
62,450
-120,400
-66% -$16.2M 0.03% 547
2022
Q4 		$24.8M Buy
182,850
+29,400
+19% +$3.69M 0.06% 329
2022
Q3 		$16.8M Sell
153,450
-121,050
-44% -$15.4M 0.03% 469
2022
Q2 		$36.3M Sell
274,500
-45,150
-14% -$5.92M 0.06% 268
2022
Q1 		$42.4M Sell
319,650
-462,150
-59% -$55.4M 0.04% 300
2021
Q4 		$91.1M Buy
781,800
+399,050
+104% +$47M 0.07% 167
2021
Q3 		$46M Buy
382,750
+56,200
+17% +$6.54M 0.05% 303
2021
Q2 		$39.1M Sell
326,550
-86,800
-21% -$9.52M 0.05% 334
2021
Q1 		$41.1M Sell
413,350
-14,700
-3% -$1.48M 0.06% 281
2020
Q4 		$42.8M Buy
428,050
+101,600
+31% +$10.8M 0.07% 223
2020
Q3 		$35.8M Buy
326,450
+70,700
+28% +$7.86M 0.11% 141
2020
Q2 		$27.1M Buy
255,750
+237,300
+1,286% +$24.5M 0.12% 146
2020
Q1 		$1.65M Sell
18,450
-14,250
-44% -$1.34M 0.01% 1172
2019
Q4 		$3.26M Sell
32,700
-2,150
-6% -$202K 0.02% 936
2019
Q3 		$3.11M Buy
34,850
+15,200
+77% +$1.32M 0.03% 888
2019
Q2 		$1.62M Buy
19,650
+1,250
+7% +$98K 0.01% 1242
2019
Q1 		$1.49M Sell
18,400
-116,600
-86% -$9.19M 0.02% 1132
2018
Q4 		$10.3M Buy
135,000
+9,600
+8% +$750K 0.09% 242
2018
Q3 		$9.92M Buy
125,400
+25,600
+26% +$1.94M 0.08% 289
2018
Q2 		$7.01M Sell
99,800
-18,000
-15% -$1.29M 0.06% 384
2018
Q1 		$8.24M Sell
117,800
-19,950
-14% -$1.38M 0.08% 283
2017
Q4 		$9.56M Sell
137,750
-110,500
-45% -$7.45M 0.07% 355
2017
Q3 		$16.8M Sell
248,250
-13,400
-5% -$847K 0.15% 127
2017
Q2 		$17.8M Sell
261,650
-16,850
-6% -$1.1M 0.19% 98
2017
Q1 		$17.3M Buy
278,500
+232,700
+508% +$13.5M 0.2% 88
2016
Q4 		$2.5M Buy
+45,800
New +$2.6M 0.02% 788

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Group One Trading's AZN Position: Q3 2025 in Review

Group One Trading sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 16,406 shares — an estimated $2.48M sold.

Group One Trading first reported a position in AZN in Q2 2014 and held it in 21 quarters. The position peaked at $24.9M in Q3 2014. 1,287 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Group One Trading reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 16,406 AstraZeneca shares in Q3 2025, an estimated $2.48M.
  • Group One Trading first reported a position in AstraZeneca in Q2 2014 and held it in 21 quarters.
  • Group One Trading's AstraZeneca position peaked at $24.9M in Q3 2014.
  • 1,287 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.